Chapter 5: Genetic Disorders Flashcards

1
Q

About what proportion of all newborn infants possess a gross chromosomal abnormality?

A

1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Serious disease with a significant genetic component develops in approximately what proportion of individuals younger than age 25 years?

A

5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define nonsense mutation.

A

A point mutation that changes an amino acid codon to a chain terminator, or stop codon.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Give one example of a disease caused by a “nonconservative” missense mutation.

A

The sickle mutation affecting the β-globin chain of hemoglobin. Here the nucleotide triplet CTC (or GAG in mRNA), which encodes glutamic acid, is changed to CAC (or GUG in mRNA), which encodes valine. This single amino acid substitution alters the physicochemical properties of hemoglobin, giving rise to sickle cell anemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give one example of a disease caused by a nonsense mutation.

A

Taking the example of β-globin, a point mutation affecting the codon for glutamine (CAG in mRNA) creates a stop codon (UAG) if C is replaced by U. This change leads to premature termination of β-globin gene translation, and the short peptide that is produced is rapidly degraded. The resulting deficiency of β-globin chains can give rise to a severe form of anemia called β0-thalassemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2 ways in which mutations within noncoding sequences may result in deleterious effects and give one example for each?

A
  • Point mutations or deletions involving promoter or enhancer sequences may interfere with binding of transcription factors and thus lead to a marked reduction in or total lack of transcription. Such is the case in certain forms of hereditary anemias called thalassemias.
  • Point mutations within introns may lead to defective splicing of intervening sequences. This, in turn, interferes with normal processing of the initial mRNA transcripts and results in a failure to form mature mRNA. Therefore translation cannot take place, and the gene product is not synthesized. Also in some cases of beta-thalassemia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

2 ways in which small deletions or insertions involving the coding sequence may result in deleterious effects and give one example for each?

A
  • If the number of base pairs involved is three or a multiple of three, the reading frame will remain intact, and an abnormal protein lacking or gaining one or more amino acids will be synthesized. Three-base deletion in the common cystic fibrosis (CF) allele results in synthesis of a protein that lacks amino acid 508 (phenylalanine). Because the deletion is a multiple of three, this is not a frameshift mutation.
  • If the number of affected coding bases is not a multiple of three, this will result in an alteration of the reading frame of the DNA strand, producing what is referred to as a frameshift mutation. Typically the result is the incorporation of a variable number of incorrect amino acids followed by truncation resulting from a premature stop codon. Four-base insertion in the hexosaminidase A (HEXA) gene, leading to a frameshift mutation. This mutation is the major cause of Tay-Sachs disease in Ashkenazi Jews.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In addition to alterations in DNA sequence, coding genes can also undergo structural variations. Give 3 types with one example for each.

A
  • Amplifications: Her2 in some cases of breast cancer
  • Deletions: 22q microdeletion syndrome
  • Translocations: So-called Philadelphia chromosome—translocation t(9;22) between the BCR and ABL genes in chronic myeloid leukemia

…that result in aberrant gain or loss of protein function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Trinucleotide-repeat mutations: give one example.

A

In fragile X syndrome (FXS), prototypical of this category of disorders, there are 250 to 4000 tandem repeats of the sequence CGG within the regulatory region of a gene called familial mental retardation 1 (FMR1). In normal populations the number of repeats is small, averaging 29. Such expansions of the trinucleotide sequences prevent normal expression of the FMR1 gene, thus giving rise to intellectual disability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define codominance and give one example.

A

Both of the alleles of a gene pair contribute to the phenotype. Histocompatibility and blood group antigens are good examples of codominant inheritance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Many autosomal dominant diseases arising from deleterious (loss-of-function) mutations fall into one of a few familiar patterns (also give one example for each)..?

A
  • Diseases involved in regulation of complex metabolic pathways that are subject to feedback inhibition. Membrane receptors such as the low-density lipoprotein (LDL) receptor provide one such example; in FH, a 50% loss of LDL receptors results in a secondary elevation of cholesterol that, in turn, predisposes to atherosclerosis in affected heterozygotes.
  • Key structural proteins, such as collagen and cytoskeletal elements of the red cell membrane (e.g., spectrin). The biochemical mechanisms by which a 50% reduction in the amounts of such proteins results in an abnormal phenotype are not fully understood. In some cases, especially when the gene encodes one subunit of a multimeric protein, the product of the mutant allele can interfere with the assembly of a functionally normal multimer. For example, the collagen molecule is a trimer in which the three collagen chains are arranged in a helical configuration. Each of the three collagen chains in the helix must be normal for the assembly and stability of the collagen molecule. Even with a single mutant collagen chain, normal collagen trimers cannot be formed, and hence there is a marked deficiency of collagen. In this instance the mutant allele is called dominant negative because it impairs the function of a normal allele. This effect is illustrated by some forms of osteogenesis imperfecta, characterized by marked deficiency of collagen and severe skeletal abnormalities.

NB: Enzyme proteins are not affected in autosomal dominant disorders; instead, receptors and structural proteins are involved.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Autosomal dominant diseases arising from deleterious (gain-of-function) mutations fall into one of a few familiar patterns (also give one example for each)..?

A
  • Some mutations result in an increase in normal function of a protein, for example, excessive enzymatic activity (no example…).
  • In other cases, mutations impart a wholly new activity completely unrelated to the affected protein’s normal function, as illustrated by Huntington disease. In this disease the trinucleotide-repeat mutation affecting the Huntington gene gives rise to an abnormal protein, called huntingtin, that is toxic to neurons, and hence even heterozygotes develop a neurologic deficit.

The transmission of disorders produced by gain-of-function mutations is almost always autosomal dominant, as illustrated by Huntington disease. In this disease the trinucleotide-repeat mutation affecting the Huntington gene gives rise to an abnormal protein, called huntingtin, that is toxic to neurons, and hence even heterozygotes develop a neurologic deficit.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Features of autosomal recessive disorders?

A
  • The trait does not usually affect the parents of the affected individual, but siblings may show the disease.
  • Siblings have one chance in four of having the trait (i.e., the recurrence risk is 25% for each birth).
  • If the mutant gene occurs with a low frequency in the population, there is a strong likelihood that the affected individual (proband) is the product of a consanguineous marriage.
  • The expression of the defect tends to be more uniform than in autosomal dominant disorders.
  • Complete penetrance is common.
  • Onset is frequently early in life.
  • Although new mutations associated with recessive disorders do occur, they are rarely detected clinically. Since the individual with a new mutation is an asymptomatic heterozygote, several generations may pass before the descendants of such a person mate with other heterozygotes and produce affected offspring.
  • Many of the mutated genes encode enzymes. In heterozygotes, equal amounts of normal and defective enzyme are synthesized. Usually the natural “margin of safety” ensures that cells with half the usual complement of the enzyme function normally.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List X-linked recessive disorders.

A
  • Duchenne muscular dystrophy
  • Hemophilia A and B
  • Chronic granulomatous disease
  • Glucose-6-phosphate dehydrogenase deficiency
  • Agammaglobulinemia
  • Wiskott-Aldrich syndrome: a disease with immunological deficiency and reduced ability to form blood clots (WAS gene)
  • Diabetes insipidus
  • Lesch-Nyhan syndrome: a rare inborn error of purine metabolism characterized by the absence or deficiency of the activity of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT)

CHAD GWenDoLiN (X-linked = male; recessive = female)
Chronic granulomatous disease
Hemophilia A and B
Agammaglobulinemia
Duchenne
G6PD deficiency
Wiskott-Aldrich
Diabetes insipidus
Lesch-Nyhan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Two examples of X-linked dominant conditions?

A
  • Vitamin D–resistant rickets
  • Alport syndrome
  • Fragile X syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What protein is affected in Phenylketonuria?

A

Phenylalanine hydroxylase

AR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What protein is affected in Tay-Sachs disease?

A

Hexosaminidase A

AR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What protein is affected in Severe combined immunodeficiency?

A

Adenosine deaminase

AR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What protein is affected in Familial hypercholesterolemia?

A

LDL receptor

AD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What protein is affected in Vitamin D–resistant rickets?

A

Vitamin D receptor

XD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What protein is affected in Marfan syndrome?

A

Fibrillin

AD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What protein is affected in Duchenne/Becker muscular dystrophy?

A

Dystrophin

XR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

2 genetic diseases affecting collagen?

A
  • Osteogenesis imperfecta
  • Ehlers-Danlos syndromes

AD (minor exceptions with EDS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What protein is affected in Hereditary spherocytosis?

A

Spectrin, ankyrin, or protein 4.1

75% AD 25% AR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What protein is affected in Hemophilia A?

A

Factor VIII

XR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What protein is affected in Cystic fibrosis?

A

Cystic fibrosis transmembrane conductance regulator

AR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

3 main organ systems affected in Marfan?

A
  • Skeleton
  • Eyes
  • Cardiovascular system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

There are two fundamental mechanisms by which loss of fibrillin leads to the clinical manifestations of Marfan syndrome?

A
  • Loss of structural support in microfibril-rich connective tissue. These fibrils provide a scaffold on which tropoelastin is deposited to form elastic fibers. Results in weakeninig of the connective tissue predominantly affecting the aorta, ligaments, and the ciliary zonules that support the lens.
  • Excessive activation of transforming growth factor (TGF)-β signaling, leading to inflammation with deleterious effects on vascular smooth muscle development, and increase in the activity of metalloproteases, causing loss of extracellular matrix.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Clinical features of Marfan?

A
  • Unusually tall stature
  • Hyperlaxity
  • Dolichocephaly with bossing of the frontal eminences and prominent supraorbital ridges
  • Spinal deformities
  • Chest deformity: pectus excavatum (deeply depressed sternum) or a pigeon-breast deformity
  • Bilateral subluxation or dislocation (usually outward and upward) of the lens, referred to as ectopia lentis
  • Mitral valve prolapse
  • Dilation of the ascending aorta due to cystic medionecrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

2 consequences of dilation of the ascending aorta due to cystic medionecrosis in Marfan?

A
  • Severe aortic incompetence
  • Aortic dissection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Name 6 types of EDS.

A
  • Classic
  • Hypermobility
  • Vascular
  • Kyphoscoliosis
  • Arthrochalasia
  • Dermatospraxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Clinical findings in vascular EDS?

A
  • Thin skin
  • Arterial or uterine rupture
  • Bruising
  • Small joint hyperextensibility
33
Q

Gene defect in vascular EDS?

A

COL3A1

34
Q

General clinical features of EDS?

A
  • Fragile, hyperextensible skin vulnerable to trauma
  • Hypermobile joints
  • Ruptures involving the colon, cornea, or large arteries
  • Wound healing is poor
35
Q

3 genes involved in familial hypercholesterolemia?

A
  • LDL receptor (85% cases)
  • ApoB protein (5% to 10% cases)
  • Activating mutations of PCSK9 (1% to 2% cases)
36
Q

Clinical features of familial hypercholesterolemia?

A
  • Hypercholesterolemia
  • Premature atherosclerosis in adult life (hetero)
  • Tendinous xanthomas
  • Skin xanthomas (homo)
  • Coronary, cerebral, and peripheral vascular atherosclerosis at an early age (homo)
  • Myocardial infarction
37
Q

An inherited deficiency of a functional lysosomal enzyme gives rise to two pathologic consequences..?

A
  • Missing enzyme –> incomplete substrate catabolism –> accumulation of the partially degraded insoluble metabolite within the lysosomes (primary accumulation) –> lysosomes become large and numerous –> disruption of normal cell functions
  • Impaired autophagy –> persistence of dysfunctional and leaky mitochondria –> generation of free radicals and releasing of molecules that trigger the intrinsic pathway of apoptosis –> also secondary accumulation of autophagic substrates including complex lipids (Gaucher) as well as ubiquitinated and aggregate-prone polypeptides such as α-synuclein (Parkinson’s disease) and Huntingtin (Huntington’s disease) protein
38
Q

Enzyme deficiency and major accumulating metabolite(s) in Pompe disease (glycogen storage disease type 2)?

A

α-1,4-Glucosidase (lysosomal glucosidase, acid alpha-glucosidase): glycogen

39
Q

Enzyme deficiency and major accumulating metabolite(s) in Krabbe disease?

A

Galactosylceramidase: Galactocerebroside

40
Q

Enzyme deficiency and major accumulating metabolite(s) in Fabry disease?

A

α-Galactosidase A: Ceramide trihexoside

41
Q

Enzyme deficiency and major accumulating metabolite(s) in Gaucher disease?

A

Glucocerebrosidase: Glucocerebroside

42
Q

Enzyme deficiency and major accumulating metabolite(s) in Niemann-Pick disease: types A and B?

A

Sphingomyelinase: Sphingomyelin

43
Q

Enzyme deficiency and major accumulating metabolite(s) in MPS I-H (Hurler)?

A

α-1-Iduronidase: Dermatan sulfate, heparan sulfate

44
Q

Enzyme deficiency and major accumulating metabolite(s) in MPS II (Hunter)?

A

Iduronate 2-sulphatase: Dermatan sulfate, heparan sulfate

45
Q

Major accumulating metabolite(s) in Tay-Sachs disease?

A

GM2 ganglioside

46
Q

Clinical features of Niemann-Pick disease type A (including Dx)?

A
  • May be present at birth and almost invariably become evident by age 6 months
  • Hepatosplenomegaly (liver and spleen involvement)
  • Progressive failure to thrive, vomiting, fever, and generalized lymphadenopathy
  • Progressive deterioration of psychomotor function (extensive neurologic involvement)
  • Death occurs usually within the first or second year of life
  • Diagnosis is established by biochemical assays for sphingomyelinase activity in peripheral blood leukocytes or bone marrow biopsy
47
Q

Clinical features of Gaucher disease type 1 (including Dx)?

A
  • Symptoms and signs first appear in adult life
  • Hepatosplenomegaly (liver and spleen involvement)
  • Pancytopenia or thrombocytopenia secondary to hypersplenism
  • Pathologic fractures and bone pain occur if there has been extensive expansion of the marrow space (bone marrow involvement)
  • Compatible with long life
  • 20-fold higher risk of developing Parkinson disease (compared with controls)
  • Diagnosis is established (in homozygotes) by biochemical assays for glucocerebrosidase activity peripheral blood leukocytes or in extracts of cultured skin fibroblasts
  • Replacement therapy with recombinant enzymes
48
Q

Genetics of Niemann-Pick disease type A?

A
  • Typically inherited as an autosomal recessive
  • Missense mutation causing almost complete deficiency of sphingomyelinase
  • Heterozygotes who inherit the mutant allele from the mother can develop the disease because the gene for acid sphingomyelinase is one of the imprinted genes that is preferentially expressed from the maternal chromosome as a result of epigenetic silencing of the paternal gene
  • Common in Ashkenazi Jews
49
Q

Genetics of Gaucher disease type 1?

A
  • Cluster of autosomal recessive disorders resulting from mutations in the gene encoding glucocerebrosidase
  • Common in Ashkenazi Jews
50
Q

Main cause of trisomy 21?

A

Advances maternal age: meiotic nondisjunction of chromosome 21 occurring in the ovum (the reason for the increased susceptibility of the ovum to nondisjunction is unknown)

51
Q

Most common mechanisms for Down syndrome?

A
  • Meiotic nondisjunction of chromosome 21 occurring in the ovum resulting in trisomy 21/an extra chromosome 21; 47,XY,+21 (95%)
  • Robertsonian translocation of the long arm of chromosome 21 (familial DS) to another acrocentric chromosome (13, 14, 15, 21, 22); for example 46,XX,t(14;21) or 45,XX,t(21;21) (4%)
  • Mitotic nondisjunction of chromosome 21 during an early stage of embryogenesis resulting in a mosaic characterized by a mixture of cells with 46 or 47 chromosomes; 46,XY/47,XY,+21 (1%) –> results in milder phenotype
52
Q

Clinical features of Down syndrome?

A
  • Flat facial profile
  • Oblique palpebral fissures
  • Epicanthic folds
  • Simian crease
  • Abundant neck skin
  • Umbilical hernia
  • Hypotonia
  • Sandal gap
  • Intellectual disability
  • Congenital heart diseases (40%): atrioventricular septal defects, ventricular septal defects, atrial septal defects, and tetralogy of Fallot
  • Other congenital malformations, including atresias of the esophagus and small bowel
  • High risk of developing leukemia: acute B lymphoblastic leukemias (20x) and acute myeloid leukemias (500x; most commonly acute megakaryoblastic leukemia)
  • Neuropathologic changes characteristic of Alzheimer disease
  • Abnormal immune responses: serious infections (++ of the lungs) and thyroid autoimmunity
53
Q

Trisomy 18/Edwards syndrome’s karyotypes?

A
  • Trisomy type: 47,XX,+18
  • Mosaic type: 46,XX/47,XX,+18
54
Q

Trisomy 13/Patau syndrome’s karyotypes?

A
  • Trisomy type: 47,XX,+13
  • Translocation type: 46,XX,t(13;14)
  • Mosaic type: 46,XX/47,XX,+13
55
Q

Clinical features of trisomy 18/Edwards syndrome?

A
  • Intellectual disability
  • Prominent occiput
  • Micrognathia
  • Low set ears
  • Short neck
  • Overlapping fingers
  • Congenital heart defects: VSD, ASD, PDA
  • Renal malformations (horseshoe kidney)
  • Limited hip abduction
  • Rocker-bottom feet

Upon reaching manhood, Sir Edwards was gifted a Big-headed horse

56
Q

Clinical features of trisomy 13/Patau syndrome?

A
  • Intellectual disability
  • Microcephaly
  • Microphtalmia
  • Cleft lip and palate
  • Polydactyly
  • Cardiac defects: VSD, PDA, ASD, and dextroposition
  • Umbilical hernia
  • Renal defects (polycystic kidney)
  • Rocker-bottom feet

NB: Defects of Eye, Nose, Lip, and Forebrain of Holoprosencephaly Type

Patau: Petite tête, Petits yeux, Polydactylie, fente Palatine, Polykystose rénale, Persistence du canal artériel, Pieds en piolet, Protubérance (hernie) ombilicale

57
Q

2 syndromes encompassed by the chromosome 22q11.2 deletion syndrome and their respective features?

A
  • DiGeorge syndrome: thymic hypoplasia with diminished T-cell immunity, congenital heart disease, and parathyroid hypoplasia with hypocalcemia
  • Velocardiofacial syndrome: congenital heart disease involving outflow tracts, facial dysmorphism, and developmental delay
58
Q

Genetic definition of Klinefelter syndrome?

A

Two or more X chromosomes and one or more Y chromosomes

59
Q

Clinical features of Klinefelter?

A
  • Eunuchoid body habitus with abnormally long legs
  • Small atrophic testes often associated with a small penis (hypogonadism and infertility)
  • Lack of such secondary male characteristics as deep voice, beard, and male distribution of pubic hair
  • Gynecomastia may be present
  • Average to below average cognitive abilities with modest deficit in verbal skills
  • Increased incidence of type 2 diabetes
  • Higher risk for congenital heart disease, particularly mitral valve prolapse
  • Increased incidence of osteoporosis and fractures (hormonal imbalance)
  • 20- to 30-fold higher risk of developing extragonadal germ cell tumors, mostly mediastinal teratomas
  • Increased incidence of breast cancer
  • Increased incidence of autoimmune diseases (e.g., SLE)
60
Q

Klinefelter karyotypes?

A
  • 47,XXY
  • 46,XY/47,XXY
  • Mosaic with a cell line with structurally abnormal X chromosome (e.g., 47,X,iXq,Y)
61
Q

Molecular pathogenesis of Klinefelter?

A

Maternal and paternal (50/50) nondisjunction at the first meiotic division.

62
Q

Turner karyotypes?

A
  • Classic: 45,X
  • Defective second X chromosome: 46,X,i(X)(q10), 46,X,del(Xq), 46,X,del(Xp), 46,X,r(X)
  • Mosaics: (1) 45,X/46,XX, (2) 45,X/46,XY, (3) 45,X/47,XXX, or (4) 45,X/46,X,i(X)(q10)
63
Q

Clinical features of Turner syndrome?

A
  • Short stature
  • Cystic hygroma
  • Peripheral lymphedema at birth
  • Webbing of neck
  • Low posterior hairline
  • Broad chest and widely spaced nipples
  • Congenital heart disease (25% to 50%): left-sided cardiovascular abnormalities, particularly preductal coarctation of the aorta and bicuspid aortic valve
  • Aortic root dilatation (30%), and there is a 100-fold higher risk of aortic dissection
  • Cubitus valgus
  • Streak ovaries, infertility, amenorrhea
  • Pigmented nevi
64
Q

Molecular pathogenesis of Turner?

A

In approximately 80% of cases the X chromosome is maternal in origin, suggesting that there is an abnormality in paternal gametogenesis.

65
Q

Klinefelter: histology of testicular biopsy?

A
  • Totally atrophied testicular tubules replaced by pink, hyaline, collagenous ghosts
  • Apparently normal tubules interspersed with atrophic tubules
  • Primitive tubules consisting of cords of cells that never developed a lumen or progressed to mature spermatogenesis
  • Leydig cell hyperplasia
66
Q

Examples of trinucleotide-repeat disorders, gene and protein..?

A
  • Fragile X syndrome, FMR1 (familial mental retardation 1), FMR-1 protein (FMRP) (expansions affecting noncoding regions)
  • Friedreich ataxia, FXN, frataxin (expansions affecting noncoding regions)
  • Myotonic dystrophy, DMPK, myotonic dystrophy protein kinase (DMPK) (expansions affecting noncoding regions)
  • Huntington disease, HTT, huntingtin (expansions affecting coding regions)
67
Q

Clinical features of FXS?

A
  • Severe intellectual disability
  • Long face with a large mandible
  • Large everted ears
  • Large testicles (macro-orchidism)
  • Hyperextensible joints (mimics connective tissue disorder)
  • High arched palate (mimics connective tissue disorder)
  • Mitral valve prolapse (mimics connective tissue disorder)
  • Epilepsy (30%)
  • Aggressive behavior 90%)
  • Autism spectrum disorder (50%)
  • Anxiety disorder/hyperactivity disorder (75%)
68
Q

Molecular pathogenesis of FXS.

A

It seems that during the process of oogenesis, but not spermatogenesis, premutations (55 to 200 CGG repeats) can be converted to full mutations (4000 repeats) by triplet-repeat amplification.

69
Q

Dx of FXS?

A

Although demonstration of an abnormal karyotype led to the identification of this disorder, polymerase chain reaction (PCR)–based detection of the repeats is now the method of choice for diagnosis.

70
Q

Mutations in mitochondrial genes: prototypic disorder?

A

Leber hereditary optic neuropathy

71
Q

Clinical features of Prader-Willi syndrome?

A
  • Intellectual disability
  • Short stature
  • Hypotonia
  • Profound hyperphagia
  • Obesity
  • Small hands and feet
  • Hypogonadism
72
Q

Molecular pathogenesis of Prader-Willi syndrome?

A
  • In about 70% of cases, an interstitial deletion of band q12 in the long arm of chromosome 15, del(15)(q11.2q13), can be detected. In most cases the breakpoints are the same, causing a 5-Mb deletion. It is striking that in all cases the deletion affects the paternally derived chromosome 15.
  • Maternal uniparental disomy (20% to 25%).
  • Defective imprinting (1% to 4%). In some patients with Prader-Willi syndrome, the paternal chromosome carries the maternal imprint (hence there are no functional alleles).

NB: This region contains the paternally expressed (maternally imprinted) SNORP family of genes and the maternally expressed (paternally imprinted) gene UBE3A.

73
Q

Molecular pathogenesis of Angelman syndrome?

A
  • Interstitial deletion of band q12 in the long arm of chromosome 15, del(15)(q11.2q13), affecting the maternally derived chromosome 15.
  • Paternal uniparental disomy (20% to 25%).
  • Defective imprinting (1% to 4%). In some patients with Angelman syndrome, the maternal chromosome carries the paternal imprint (hence there are no functional alleles).

NB: This region contains the paternally expressed (maternally imprinted) SNORP family of genes and the maternally expressed (paternally imprinted) gene UBE3A.

74
Q

Clinical features of Angelman syndrome?

A
  • Intellectual disability
  • Microcephaly
  • Ataxic gait
  • Seizures
  • Inappropriate laughter
75
Q

Dx of Prader-Willi/Angelman?

A
  • Methylation analysis via PCR &/or Southern blotting done first on 15q11-13 (cannot distinguish between uniparental disomy or deletion as mechanism of cause of PWS and AS)
  • FISH &/or karyotype can be used to determine method of inheritance
76
Q

Indications for analysis of inherited genetic alterations in the prenatal period, and method of choice?

A
  • Advanced maternal age
  • A parent known to carry a balanced chromosomal rearrangement, which greatly increases the frequency of abnormal chromosome segregation during meiosis and the risk of aneuploidy in the fertilized ovum
  • Fetal anomalies observed on ultrasound
  • Routine maternal blood screening indicating an increased risk of Down syndrome (trisomy 21) or another trisomy
  • Fetuses at known risk for Mendelian disorders (e.g., cystic fibrosis, spinal muscular atrophy) based on family history

NB: Usually performed on cells obtained by amniocentesis, chorionic villus biopsy, or umbilical cord blood. However, as much as 10% of the free DNA in a pregnant mother’s blood is of fetal origin, and new sequencing technologies have opened the door to an era of noninvasive prenatal diagnostics utilizing this source of DNA (circulating free fetal DNA).

77
Q

Indications for analysis of inherited genetic alterations in the postnatal period, and method of choice?

A
  • Multiple congenital anomalies
  • Suspicion of a metabolic syndrome
  • Unexplained intellectual disability, and/or developmental delay
  • Suspected aneuploidy (e.g., features of Down syndrome) or other syndromic chromosomal abnormality (e.g., deletions, inversions)
  • Suspected monogenic disease, whether previously described in the family or new

NB: Most commonly performed on peripheral blood DNA and is targeted based on clinical suspicion.

78
Q

Indications for analysis of inherited genetic alterations in the postnatal period, and method of choice?

A
  • Multiple congenital anomalies
  • Suspicion of a metabolic syndrome
  • Unexplained intellectual disability, and/or developmental delay
  • Suspected aneuploidy (e.g., features of Down syndrome) or other syndromic chromosomal abnormality (e.g., deletions, inversions)
  • Suspected monogenic disease, whether previously described in the family or new

NB: Most commonly performed on peripheral blood DNA and is targeted based on clinical suspicion.